Home › Myelodysplastic Syndromes › New York › Rochester
Myelodysplastic Syndromes clinical trials in Rochester, NY
6 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Rochester General Hospital, Rochester
- University of Rochester, Rochester
A Telehealth Advance Care Planning Intervention
Recruiting
- University of Rochester, Rochester
Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
RecruitingEarly phase 1
- Wilmot Cancer Institute, University of Rochester, Rochester
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
RecruitingPhase 1/2
- The University of Rochester, Rochester
Umbilical Cord Blood Transplantation From Unrelated Donors
RecruitingObservational study
- Wilmot Cancer Institute, Rochester
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
RecruitingObservational study
- University of Rochester Medical Center, Rochester
About Myelodysplastic Syndromes
Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.
More about Myelodysplastic Syndromes on MedlinePlus
Myelodysplastic Syndromes trials in other cities
- Houston, TX43 studies
- Baldwin Park, CA26 studies
- New York City, NY21 studies
- Seattle, WA21 studies
- Washington, DC20 studies
- Tampa, FL19 studies
- Boston, MA19 studies
- Miami, FL17 studies
- Durham, NC14 studies
- Columbus, OH14 studies
- St. Louis, MO13 studies
- Atlanta, GA13 studies
Other studies in Rochester
- Acute Myeloid Leukemia16 studies
- Lung Cancer15 studies
- Breast Cancer15 studies
- Cancer (all types)14 studies
- Obesity14 studies
- Overweight13 studies
- Non-Small Cell Lung Cancer13 studies
- Prostate Cancer10 studies
- Metastatic Cancer8 studies
- Multiple Myeloma8 studies
- Bladder Cancer7 studies
- Myotonic Dystrophy7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.